Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I TrialRuihao Huang, Xi Zhang, Cheng Zhang et al.|Blood|2022Cited by 33
P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIALRuihao Huang, X Zhang, Maihong Wang et al.|HemaSphere|2023Cited by 5